| Financial Year |
March 31 2023 |
| Monetary Funds |
549,484,140.18 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
2,320,524,013.87 |
| Advances to Suppliers |
21,330,288.49 |
| Other Receivables |
45,838,665.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
248,873,173.44 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
108,576,124.55 |
| Total Current Assets |
3,294,626,406.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,738,508.38 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
5,504,222,709.70 |
| Under-construction Projects |
356,378,527.14 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
833,152,919.20 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
20,398,545.01 |
| Deferred Income Tax Assets |
35,244,255.21 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
6,765,598,472.27 |
| Total Assets |
10,060,224,878.32 |
| Short-Term Loans |
635,944,336.94 |
| Trading Financial liabilities |
-- |
| Notes Payable |
212,549,087.31 |
| Accounts Payable |
709,718,164.65 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
23,354,681.67 |
| Taxes Payable |
28,463,147.48 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
349,993,715.76 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
858,098,826.34 |
| Other Current Liabilities |
1,950,656.61 |
| Sub-Total of Current Liabilities |
2,846,738,191.98 |
| Long-term Loans |
3,766,813,584.62 |
| Bonds Payable |
760,964,628.61 |
| Long-Term Accounts Payable |
118,439,820.94 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,685,256,086.26 |
| Total Liabilities |
7,531,994,278.24 |
| Paid-In Capital(Or Share Stock) |
741,952,476.00 |
| Capital Surplus |
841,822,604.05 |
| Surplus Reserve |
147,671,914.35 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
659,132,416.24 |
| Minority Stockholder's Interest |
10,749,470.72 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,517,481,129.36 |
| Owner's Equity（Stockholder's Equity） |
2,528,230,600.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,060,224,878.32 |
